Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG NYSE:JNJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$473.84+0.6%$501.89$425.00▼$616.00$168.90B1.591.99 million shs1.55 million shsJNJJohnson & Johnson$175.50-0.7%$164.95$140.68▼$181.16$425.77B0.418.63 million shs6.42 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-0.66%-1.94%-4.62%-15.22%-2.32%JNJJohnson & Johnson+0.03%-1.07%+6.32%+15.15%+8.43%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationISRGIntuitive Surgical4.8827 of 5 stars4.33.00.04.03.52.51.9JNJJohnson & Johnson4.8747 of 5 stars2.35.04.23.94.01.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.60Moderate Buy$595.9525.77% UpsideJNJJohnson & Johnson 2.65Moderate Buy$176.290.45% UpsideCurrent Analyst Ratings BreakdownLatest JNJ and ISRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/22/2025ISRGIntuitive SurgicalDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell8/21/2025JNJJohnson & JohnsonCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$185.00 ➝ $200.008/20/2025ISRGIntuitive SurgicalZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/19/2025ISRGIntuitive SurgicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$615.007/23/2025ISRGIntuitive SurgicalUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$547.00 ➝ $585.007/23/2025ISRGIntuitive SurgicalPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$575.00 ➝ $595.007/23/2025ISRGIntuitive SurgicalTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$590.00 ➝ $600.007/23/2025ISRGIntuitive SurgicalWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$559.00 ➝ $599.007/23/2025ISRGIntuitive SurgicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$605.00 ➝ $615.007/23/2025ISRGIntuitive SurgicalErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold7/23/2025ISRGIntuitive SurgicalBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$566.00 ➝ $571.00(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$8.35B20.34$7.98 per share59.37$50.08 per share9.46JNJJohnson & Johnson$88.82B4.76$13.05 per share13.45$32.58 per share5.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.32B$7.1766.0962.104.9728.51%14.56%12.93%10/16/2025 (Estimated)JNJJohnson & Johnson$14.07B$9.3518.7715.852.2525.00%32.49%13.00%10/21/2025 (Estimated)Latest JNJ and ISRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025ISRGIntuitive Surgical$1.93$2.19+$0.26$1.81$2.35 billion$2.44 billion7/16/2025Q2 2025JNJJohnson & Johnson$2.68$2.77+$0.09$2.29$22.85 billion$23.74 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/AJNJJohnson & Johnson$5.202.96%N/A55.61%64 YearsLatest JNJ and ISRG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/16/2025JNJJohnson & Johnsonquarterly$1.303.35%8/26/20258/26/20259/9/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A5.174.18JNJJohnson & Johnson0.501.010.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%JNJJohnson & Johnson69.55%Insider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.70%JNJJohnson & Johnson0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical12,100358.48 million355.97 millionOptionableJNJJohnson & Johnson152,7002.41 billion2.40 billionOptionableJNJ and ISRG HeadlinesRecent News About These CompaniesJ&J drops development of combination arthritis drug5 hours ago | reuters.comJohnson & Johnson $JNJ Shares Sold by D L Carlson Investment Group Inc.August 28 at 8:36 AM | marketbeat.comTruvestments Capital LLC Grows Stock Position in Johnson & Johnson $JNJAugust 28 at 8:34 AM | marketbeat.comB. Metzler seel. Sohn & Co. AG Buys 6,407 Shares of Johnson & Johnson $JNJAugust 28 at 8:10 AM | marketbeat.comGuggenheim Capital LLC Raises Stake in Johnson & Johnson $JNJAugust 28 at 7:36 AM | marketbeat.comJohnson & Johnson $JNJ Stake Raised by CreativeOne Wealth LLCAugust 28 at 7:35 AM | marketbeat.comIeq Capital LLC Raises Stake in Johnson & Johnson $JNJAugust 28 at 7:13 AM | marketbeat.comRedwood Investment Management LLC Acquires 3,599 Shares of Johnson & Johnson $JNJAugust 28 at 6:33 AM | marketbeat.comGamco Investors INC. ET AL Reduces Stock Position in Johnson & Johnson $JNJAugust 28 at 6:33 AM | marketbeat.comFORA Capital LLC Lowers Position in Johnson & Johnson $JNJAugust 28 at 6:13 AM | marketbeat.comJump Financial LLC Reduces Stake in Johnson & Johnson $JNJAugust 28 at 5:19 AM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading Down 1.1% - Time to Sell?August 27 at 2:10 PM | marketbeat.comJohnson & Johnson $JNJ Shares Sold by Samalin Investment Counsel LLCAugust 27 at 8:38 AM | marketbeat.comJohnson & Johnson $JNJ Shares Sold by Rafferty Asset Management LLCAugust 27 at 8:11 AM | marketbeat.comEpoch Investment Partners Inc. Decreases Holdings in Johnson & Johnson $JNJAugust 27 at 8:09 AM | marketbeat.comHarvest Portfolios Group Inc. Has $57.17 Million Stock Position in Johnson & Johnson $JNJAugust 27 at 7:26 AM | marketbeat.comCiti Lifts Johnson & Johnson (JNJ) Price Target to $200 on MedTech StrengthAugust 26 at 12:57 AM | msn.comInvestors Purchase High Volume of Johnson & Johnson Call Options (NYSE:JNJ)August 26 at 3:29 PM | marketbeat.comAs the Market Rotates, This Healthcare ETF Is Leading the Way (JNJ)...August 26 at 9:35 AM | marketbeat.comJohnson & Johnson $JNJ Shares Sold by South Plains Financial Inc.August 26 at 8:47 AM | marketbeat.comCaisse DE Depot ET Placement DU Quebec Raises Stock Holdings in Johnson & Johnson $JNJAugust 26 at 8:39 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025An Atomic Sized Surge Is Brewing for NuScale Power Stock PriceBy Thomas Hughes | August 11, 2025Worried About a Fading Rally? Consider These 3 Dividend StocksBy Dan Schmidt | August 11, 2025JNJ Stock Surge Signals Confidence in New Growth PathBy Jeffrey Neal Johnson | August 25, 2025JNJ and ISRG Company DescriptionsIntuitive Surgical NASDAQ:ISRG$473.84 +2.69 (+0.57%) Closing price 04:00 PM EasternExtended Trading$471.90 -1.94 (-0.41%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.Johnson & Johnson NYSE:JNJ$175.50 -1.29 (-0.73%) Closing price 03:59 PM EasternExtended Trading$176.04 +0.54 (+0.31%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It NIO Just Got Its Second Upgrade of the Month, and It’s Big Chevron Stock Outlook: Dividend Growth Meets Inflation As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes Back Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access